Benefícios do tratamento com Hibiscus sabdariffa para a obesidade, doenças associadas e seus efeitos adversos

Obesity is a chronic metabolic disease caused by an imbalance in food intake and energy expenditure, being associated with an increase in adipogenesis. Hibiscus sabdariffa, considered the second most studied plant after green tea, is used against inflammation, obesity, dyslipidemia, hypertension and liver disease. This study aimed to investigate the effects of H. sabdariffa in the treatment of these pathologies and adverse reactions. In vitro studies indicate that H. sabdariffa, administered at a concentration of 2.5 mg/ml, had anti-lipase and anti-amylase activity. In another study, 450 mg of H. sabdariffa extract, administered 3 times a day for 12 weeks, demonstrated a reduction in body weight in women. In one investigation, the same extract lowered blood cholesterol in teenagers when administered at a concentration of 2 g per day for 30 days. In another study, there was an adverse reaction interfering with spermatogenesis in male rats, impairing their fertility. H. sabdariffa had beneficial effects for the adjunctive treatment of obesity and associated diseases, but further clinical trials on the safety and efficacy of this plant are needed.

Authors

Institutions

Publication Details

Journal
Revista Brasileira de Plantas Medicinais
Published
2024-09-18
DOI
https://doi.org/10.70151/zra53r95
Primary Topic
Hibiscus Plant Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Benefícios do tratamento com Hibiscus sabdariffa para a obesidade, doenças associadas e seus efeitos adversos

Bruno Oliveira, Renata Jesus Santos Cancellara, Alexandra Corrêa de Freitas
Revista Brasileira de Plantas Medicinais
Hibiscus Plant Research Studies
article

Benefícios do tratamento com Hibiscus sabdariffa para a obesidade, doenças associadas e seus efeitos adversos

Bruno Oliveira, Renata Jesus Santos Cancellara, Alexandra Corrêa de Freitas
article en

Abstract

Obesity is a chronic metabolic disease caused by an imbalance in food intake and energy expenditure, being associated with an increase in adipogenesis. Hibiscus sabdariffa, considered the second most studied plant after green tea, is used against inflammation, obesity, dyslipidemia, hypertension and liver disease. This study aimed to investigate the effects of H. sabdariffa in the treatment of these pathologies and adverse reactions. In vitro studies indicate that H. sabdariffa, administered at a concentration of 2.5 mg/ml, had anti-lipase and anti-amylase activity. In another study, 450 mg of H. sabdariffa extract, administered 3 times a day for 12 weeks, demonstrated a reduction in body weight in women. In one investigation, the same extract lowered blood cholesterol in teenagers when administered at a concentration of 2 g per day for 30 days. In another study, there was an adverse reaction interfering with spermatogenesis in male rats, impairing their fertility. H. sabdariffa had beneficial effects for the adjunctive treatment of obesity and associated diseases, but further clinical trials on the safety and efficacy of this plant are needed.

Revista Brasileira de Plantas MedicinaisVol. 21(3)
Hospital de Câncer de Barretos (BR), Hospital Santa Marcelina (BR), Faculdade Santa Marcelina (BR)
Openalex Percentile: Top 65%
Hibiscus Plant Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Benefícios do tratamento com Hibiscus sabdariffa para a obesidade, doenças associadas e seus efeitos adversos — Bruno Oliveira, Renata Jesus Santos Cancellara, et al. · Revista Brasileira de Plantas Medicinais (2024) | TGRS Research Map | TGRS